August 13, 2024

Mass Spec Down Under: IMSC Is Here!

Find out what’s happening at IMSC 2024 with our top selections from the program…

The Pathologist

January 28, 2025

FDA Approves Enhertu for Metastatic, HR-Positive, HER2-Low or -Ultralow Breast Cancer

Enhertu, a HER2-directed antibody-drug conjugate, was approved by the U.S. Food and Drug Administration for pretreated patients with metastatic HR-positive, HER2-low or HER2-ultralow breast cancer based on results from the DESTINY-Breast06 trial.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant

June 03, 2025

Plant Diet May Delay Myeloma Precursor Progression

First clinical trial shows high-fiber plant-based diet improves microbiome and may delay MGUS/SMM progression to multiple myeloma.

Conexiant

March 31, 2025

Microplastics Linked to Cardiovascular Disease

Research reveals significant associations between environmental microplastic pollution and increased rates of hypertension, diabetes, and stroke across U.S. coastal communities, with pollution levels ranking among top predictors for chronic disease prevalence.

Conexiant

March 25, 2025

Microplastics: Chewing Gum May Release Particles Into Saliva

"Surprisingly, both synthetic and natural gums had similar amounts of microplastics released when we chewed them."

Conexiant

June 17, 2025

Aconitine Tames Joints, Protects Bone

At EULAR 2025, researchers presented data showing aconitine reduced bone erosion and increased regulatory T cells in a rheumatoid arthritis mouse model.

Conexiant

December 20, 2023

Hands on at USCAP

Check out our series of videos filmed at USCAP 2023, featuring Epredia and Owkin.

The Pathologist

October 18, 2024

SciX Enters the AI Age

From AI-driven diagnostics to tales of viking treasures, check out our must-see SciX 2024 highlights

The Pathologist